In the global medical devices industry, there were 32 private equity deals announced in Q2 2023, worth a total value of $3.7bn, according to GlobalData’s Deals Database. The $2.1bn institutional buy-out (ibo) oneoncology by AmerisourceBergen and TPG Capital was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.

In value terms, private equity deal activity increased by 891% in Q2 2023 compared with the previous quarter’s total of $373.5m and rose by 47% as compared to Q2 2022. Related deal volume increased by 28% in Q2 2023 versus the previous quarter and was 9% lower than in Q2 2022.

Notably, foreign direct investments (fdi)-related deals accounted for a 47% share of the global medical devices industry’s private equity deal activity in Q2 2023, up 150% over the previous quarter.

The top-ranked financial advisors supporting these private equity deals in Q2 2023 were Piper Sandler Companies; Houlihan Lokey; Canaccord Genuity Group with 3, 2, 1 deals respectively.

The top-ranked legal advisors supporting these private equity deals in Q2 2023 were Kirkland & Ellis; Allen & Overy; Latham & Watkins with 4, 2, 2 deals respectively.

For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.